Survive To Thrive – Office Hours Workshop

Survive To Thrive – Office Hours Workshop

Date: August 19, 2020 Time: 12:00 - 1:30 Zoom

When Global Disasters Strike: Supply Chain Repercussions – Panel Discussion & Role Play
  • A presentation and interactive role-play and case study addressing supply chain and business disruption in light of the global pandemic
  • A foundation of key legal and commercial issues focused on vendor and customer relationships relating to supply chain and business disruptions
  • An overview of a flexible risk mitigation and contracts review process that can be tailored to the needs of a wide rang
  • A demonstration of how these principles and processes can be applied in practice by engaging in an interactive role-play and case study
  • A simulation of customer, supplier and legal counsel interactions
Attend and ask questions or just listen and learn.


Stephanie Sharron
Morisson & Foerster
Stephanie is recognized as a trusted advisor to both private and public companies, from emerging growth through the Fortune 50, assisting them with technology and life sciences transactions. Stephanie has 30+ years of experience working with clients on the complex technology, commercial, intellectual property, and data rights issues across technology and industry sectors. Her clients’ businesses include, among others: cloud services, artificial intelligence, machine learning, data analytics, the Internet of Things (IoT), FinTech, Life Sciences, digital transactions, autonomous systems, cybersecurity solutions, semiconductors, HealthTech, EdTech and CleanTech. Additionally, Stephanie advises on the commercial technology and intellectual property aspects of mergers, acquisitions, asset spin-off transactions, and private equity investments.

Most recently, Stephanie has presented and published extensively on the legal problem-solving to address supply chain disruption in light of the global pandemic. Stephanie also is recognized as a thought leader regarding the contractual and legal issues at the intersection of data and technology. Since 2016, Stephanie has taught as a guest lecturer in the Technology Transactions course in Cornell Law school’s Technology and Entrepreneurship LLM program at CornellTech. She also was adjunct faculty at Cornell Law School for a Legal Issues in FinTech course.

Ken Epstein
NewCap Partners, Inc.
Award-winning Senior level executive with 30+ years of experience as a registered investment banker, Ken Epstein provides advice to entrepreneurs, business owners of private and family-owned companies, as well as to global corporations, private equity, and other financial groups on matters related to sell-side and buy-side mergers and acquisitions, corporate development and partnerships, and targeted equity capital raises. Ken uses his many years of U.S. and global experience in international investment banking as well as corporate venture management (including P&L responsibility for both major business units and startups) and background in advanced materials, renewables, healthcare, and industrial markets to help his clients.

Ken focuses his M&A and targeted capital financing activities on the Materials (resins, additives, specialty chemicals, ceramics, carbon fibers, composites, nanotechnology, biomaterials), Materials Manufacturing into Parts (additive manufacturing, extrusion, injection molding), Life Sciences (medical devices/diagnostics/health-IT services), Renewables (water, energy storage, fuel cells, solar, wind), and Industrial/Aerospace/Transportation markets.

In addition, having spent many years working on international projects, Ken has developed an international network to help NewCap’s clients explore global options. In the past 10 years, Ken has helped companies find partners in Japan, Southeast Asia, China, Europe, Brazil, and Canada and he is currently initiating activities in Australia and Korea.

Robert Winter
Robert has invested in over 35 early-stage startups (from information technologies to life sciences and material) – 1/2 with positive exit (of which 1/2 or 1/4 of total were successful IPOs), 1/4 failed, 1/4 unrealized – for a lifetime realized 6x cash-on-on equity return.

Venture Capital – e.g., nVidia, NetApps, Pharmacyclics, Financial Interactive

Angel – e.g., eHealthlnsurance, Active Network,, BiologicsMD, ZoMazz, TNG Pharma, Numat, SiNode, Medical Adhesions Revolution, neurable, DryLet, Gecko Robotics

He co-founded a special situation private equity fund, daVinci Capital Group, which invest in technology and life science companies. Prior, he was a Founding Managing Partner of Rocket Ventures, a $75M early-stage venture capital firm focused on software, Internet and semiconductors. Previously, he founded Menlo Park Group where he identified technology-oriented buyout targets and provided strategic consulting to corporations and entrepreneurial ventures. Earlier, Robert was a General Partner at Comdisco Ventures and Senior Associate at Canaan Partners. He has served in senior management positions at Hewlett-Packard, Informatics General Corporation and IBM. Robert is an active angel investor and serves on start-up company boards and a number of non-profits. He holds a BSEE Rice University and an MBA from Harvard University.


12:00 – 01:30 Workshop Begins

Submit questions during registration
Submit questions in writing during the program
01:30 Program ends

Program Chair

Tina Wang

During registration you have the opportunity to provide questions you would like our panelists to answer.

Join our Email List to stay informed about our upcoming events.
Click Here!